Serelys Pharma

About Serelys Pharma

Sérélys Pharma is a leader in women's health, now launching Femaxeen®, a brand new patent-pending, natural solution for women’s urinary incontinence, documented by a randomized, double-blind, placebo-controlled study. This study documents that Femaxeen® significantly reduces women’s involuntary urine leaks versus placebo by over 45% within 2 months in all types of urinary incontinence (urge, stress and mixed), with no known side effects. Furthermore, Femaxeen® continues the company’s tradition of commercializing products based on exclusive, proprietary technology and this new product o...

  • MC
  • 2018
    On CPHI since
  • 25 - 49
    Employees
Company types
Manufacturer/Innovator
Contact info
  • Le Triton, 5 rue du Gabian, 98 000 , Monaco, Monaco
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from Serelys Pharma (1)

  • SÉRÉLYS MENO

    Product SÉRÉLYS MENO

    SÉRÉLYS MENO, is a scientifically documented food supplement (preclinical and clinical studies with more than 1000 patients), endorsed by leading international gynaecologists KOL. It is based on our PureCytonin technology and has a unique non-hormonal mode of action. With its proven efficacy and safety, SÉ...

Serelys Pharma Resources (1)

  • Brochure Sérélys Pharma

    Sérélys Pharma offers a range of proprietary, scientifically documented food supplements, focused on women's health. Serelys Meno, our flagship product, is the credible alternative to hormone replacement therapy for menopausal symptoms. It is the market leader in the natural menopause category in several European countries.Sérélys Pharma products are based on a proprietary ingredient, "Purified and Specific Cytoplasmic Pollen Extracts", obtained through an exclusive technology called CyTonin® Technology.